Abstract:Introduction and Objectives: Subjects without cardiovascular (CV) disease (CVD) may suffer from subclinical atherosclerosis, and are at increased risk for atherosclerotic CV events (ASCVE). The ESC/EAS risk SCORE was updated by SCORE2, which estimates 10-year risk of fatal and non-fatal CVD in European populations aged 40-69 years without established CVD or diabetes. Our aim was to compare the two ESC/EAS risk scores and to validate SCORE2 in our population. Methods: A total of 1071 individuals (age 57.2±6.1 years; 75.2% male) without CVD or diabetes, from GENEMACOR study controls, were analyzed over 5.4±3.9 years. The population was stratified into risk categories according to the two scores, and the area under the ROC curve (AUC) and Harrell's C-index assessed the scores' performance. Calibration was performed using the goodness-of-fit test, and occurrence of the first event assessed by Cox regression. Kaplan-Meier analysis estimated SCORE2 survival. Results: SCORE stratified subjects into four risk categories: low (7.4%), moderate (46.5%), high (25.3%) and very high (20.8%), and SCORE2 into three: low-to-moderate (24.7%), high (59.0%) and very high (16.2%). SCORE presented good discrimination for CV mortality (AUC=0.838; C-index=0.834, 95% CI: 0.728-0.940), as did SCORE2 for total CV events (AUC=0.744; C-index=0.728, 95% CI: 0.648-0.808). Calibration did not show a disparity between observed and expected ASCVE. The probability of ASCVE was eight times higher in very-high-risk SCORE2 (p=0.001), and three times in the high-risk group (p=0.049). Event-free survival was 99%, 90% and 72% in the low-to-moderate, high and very-high-risk categories, respectively (p<0.0001). Conclusions: SCORE2 improved population stratification by identifying higher-risk patients, enabling early preventive measures. It showed good discriminative ability for all ASCVE. Resumo Introdução e objetivos: Indivíduos sem doença cardiovascular (DCV) sintomática podem sofrer de aterosclerose subclínica tendo risco de eventos cardiovasculares (ECV). O SCORE Europeu foi atualizado pelo SCORE2 que estima o risco de DCV fatal e não fatal a 10 anos, nos europeus entre 40 e 69 anos, sem DCV ou diabetes. O objetivo é comparar estes dois scores de risco, validando o SCORE2 na nossa população. Métodos: 1071 indivíduos (57,2±6,1anos; 75,2%sexo masculino), sem DCV ou diabetes, foram seguidos durante 5,4±3,9 anos e estratificados em categorias de risco. O poder discriminativo dos scores para ECV foi estimado pela área abaixo da curva ROC (AUC) e pelo índice C de Harrell. A calibração foi avaliada pelo Hosmer-Lemeshow; o risco de ocorrência do 1.o evento pela regressão de Cox. Kaplan-Meier estimou a sobrevivência do SCORE2. Resultados: O SCORE estratificou em quatro categorias de risco, baixo (7,4%), moderado (46,5%), alto (25,3%) e muito alto (20,8%) e o SCORE2 em três, baixo-a-moderado (24,7%), alto (59,0%) e muito alto (16,2%). O SCORE apresentou boa discriminação para mortalidade CV (AUC=0,838;índiceC=0,834) e o SCORE2 discriminou para a totalidade dos ECV (AUC=0,744;índiceC=0,728). A calibração foi adequada. A probabilidade de ECV aumentou oito vezes na categoria de muito alto risco (p=0,001) e três vezes na de alto risco (p=0,049). A sobrevivência livre de eventos foi 99%, 90% e 72% nas categorias de baixo-a-moderado, alto e muito alto risco, respetivamente (p<0,0001). Conclusões: O SCORE2 melhorou a estratificação ao identificar indivíduos de maior risco, permitindo medidas preventivas precocemente. Mostrou boa capacidade discriminativa para ECV.

Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example

Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands

[Study on the Efficiency of the European System for Cardiac Operative Risk Evaluation (euroscore) in Predicting In-Hospital Mortality of the Patients with Percutaneous Coronary Intervention].

Measurement of ECG abnormalities and cardiovascular risk classification: a cohort study of primary care patients in the Netherlands

SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions

Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort

Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners’ perceptions

Cardiovascular risk assessment in Portugal’s primary health care system: SCORE vs. SCORE2

Prediction of cardiovascular risk in patients type 2 diabetes using the SCORE2-Diabetes risk score

Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2

Long-term cardiovascular outcomes in a population-based multicentric cohort of northern Portugal: Validation of the ESC/EAS prognostic risk classification

Do obesity and parental history of myocardial infarction improve cardiovascular risk prediction?

Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe

Coronary artery calcification score and 19 biomarkers on cardiovascular events; a 10-year follow-up DanRisk substudy

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht Cardiovascular Cohort Initiative

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

Optimizing cardiovascular risk assessment and registration in a developing cardiovascular learning health care system: Women benefit most

Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial

Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection

Which is better for predicting and discriminating cardiovascular events: a traditional risk score, a calcium score or a genetic risk score?

The role of coronary artery calcium score and european score2 in primary prevention of cardiovascular disease